fluorobenzenes has been researched along with Impaired Glucose Tolerance in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jialal, I; Sheely, D | 1 |
| Calles-Escandon, J; Clark, PB; Gage, HD; Garg, P; Garg, S; Kavanagh, K; Morton, K; Wagner, JD | 1 |
| Acbay, O; Celik, O | 1 |
| Elisaf, MS; Florentin, M; Kei, AA; Kostapanos, MS; Liamis, G; Liberopoulos, EN; Rizos, CV | 1 |
1 trial(s) available for fluorobenzenes and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.
Topics: Aged; Allylamine; Anticholesteremic Agents; Biomarkers; Blood Glucose; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |
3 other study(ies) available for fluorobenzenes and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk.
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |
Enhanced cholinergic response in pancreata of nonhuman primates with impaired glucose tolerance shown on [18F]fluorobenzyltrozamicol positron emission tomography.
Topics: Animals; Blood Glucose; Chlorocebus aethiops; Female; Fluorine Radioisotopes; Fluorobenzenes; Glucose Intolerance; Insulin; Piperidines; Positron-Emission Tomography; Primates; Reference Values; Triglycerides | 2009 |
Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance.
Topics: Adult; Blood Glucose; Body Mass Index; Drug Combinations; Female; Fluorobenzenes; Follow-Up Studies; Glucose Intolerance; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperandrogenism; Hyperlipidemias; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Prognosis; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Testosterone | 2012 |